Skip to content
Screener

Zymeworks ZYME Other operating expenses

Other operating expenses at other companies

Shattuck Labs, Inc. logo
Shattuck Labs, Inc.STTK
$15.55M+8.0%
Apogee Therapeutics, Inc. logo
Apogee Therapeutics, Inc.APGE
$82.77M+31.2%
AbCellera Biologics Inc. logo
AbCellera Biologics Inc.ABCL
$66.83M+0.2%
Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
-1.1%

Other financials

Income statement

See full
Revenue$4.6M-90.6%
Operating income-$42.2M-6,158%
Net income-$45.0M-2,043%
EPS (diluted)-$0.62-2,167%

Balance sheet

See full
Cash & equivalents$179.4M+82.6%
Total debt$16.0M-14.3%
Total equity$80.4M-76.0%
Total assets$397.0M-2.8%

Cash flow

See full
Operating cash flow-$31.9M-365%
CapEx$216.0K+1,250%
Free cash flow-$31.9M-376%

Valuation

See full
Market cap$1.7B+83.2%
Enterprise value$1.54B+81.1%
P/S45.8×+38.3×

Profitability

See full
Operating margin-419%-518pp
Net margin-404%-489pp
FCF margin-324.7%-366pp

Returns & leverage

See full
Return on equity-72.3%-117pp
Debt / equity0.2×+0.1×
Current ratio6.3×-1.4×

Where this comes from

Reported directly by Zymeworks in its filing.

Tagged under the XBRL concept us-gaap:OtherOperatingIncomeExpenseNet.

The source filing: Zymeworks’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 4:11 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001937653-26-000047
Line itemThree Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Interest income3,2873,4265,9986,850
Interest expense related to sale of future royalties(6,595)(8,661)
Other income (expense), net196(621)316(572)
Total other (expense) income, net(3,112)2,805(2,347)6,278
(Loss) income before income taxes(45,292)2,131(91,645)(20,009)
Income tax recovery (expense)2731862,464(310)
Net (loss) income(45,019)2,317(89,181)(20,319)
Other comprehensive (loss) income:

Item 1. Financial Statements

FAQ

What is Zymeworks's other operating expenses?
Zymeworks (ZYME) reported other operating expenses of -$3.11M in Q2 2026.
How has Zymeworks's other operating expenses changed year-over-year?
Zymeworks's other operating expenses decreased by 210.9% year-over-year, from $2.81M to -$3.11M.
What is the long-term trend for Zymeworks's other operating expenses?
Over 4 years (2021 to 2025), Zymeworks's other operating expenses has grown at a 40.6% compound annual growth rate (CAGR), from $3.27M to $12.8M.
What does other operating expenses mean?
Residual operating expenses not classified into specific categories, serving as a catch-all for miscellaneous operating costs.

Ask your AI about Zymeworks's other operating expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude